Blood test markers for kidney injury in acute pancreatitis
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at two simple blood test markers (C-reactive protein and albumin) to see if their ratio can help detect kidney injury early in people with acute pancreatitis. If you have acute pancreatitis, are over 18, and do not have other major health issues, this trial might be for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with acute pancreatitis (severe belly pain, high amylase or lipase levels, or special CT findings).
- You must be over 18 years old.
- You cannot be pregnant or breastfeeding.
- You cannot have chronic kidney disease or end-stage renal disease.
- You cannot have active cancer, liver cirrhosis, or an active infection.
- You must have stayed in the hospital for more than 24 hours.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at whether routine blood test results can help doctors predict how severe acute pancreatitis will be and how well patients may recover. It aims to find simple, early clues to guide treatment.
This study looks at whether a blood test that combines a type of white blood cell (neutrophil) and a kidney measure (creatinine) can help predict how severe acute pancreatitis is and what the outcome might be for patients.
This study looks at specific blood “immune” signatures and how they relate to outcomes in people with acute pancreatitis. If you enroll early, it may help doctors better predict how the illness will go and identify who might need more care.
This study looks at whether certain blood test results (triglyceride and glucose) can help predict acute kidney injury in ICU patients. It aims to find early warning signs so doctors can act sooner.
This study tests whether a simple blood ratio (platelets to albumin) can help predict if patients will develop Acute Kidney Injury (a sudden kidney problem) while in the ICU. It may help doctors identify high-risk patients earlier.
This study analyzes immune system markers in blood samples to help predict which people with chronic pancreatitis (long-term pancreas inflammation) might develop pancreatic cancer. Researchers will compare blood patterns in healthy people, those with chronic pancreatitis, and those recently diagnosed with pancreatic cancer.
Hear when a new Acute Kidney Injuries trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.